Half of long-stay nursing home residents go to hospital ED regardless of cognitive status

by Indiana UniversityA new study from the Indiana University Center for Aging Research and the Regenstrief Institute has found that almost half of all long-stay nursing home residents experience

Updated on: February 28,2024

Half of long-stay nursing home residents go to hospital ED regardless of cognitive status

by Indiana UniversityA new study from the Indiana University Center for Aging Research and the Regenstrief Institute has found that almost half of all long-stay nursing home residents experience

Updated on:February 28,2024

Dementia care at home: Raising knowledge and confidence to improve quality and decrease costs

by New York UniversityOver two thirds or the home health care population consists of adults over the age of 65, approximately 36% have some form of cognitive impairment, including dementia. Accor

Updated on: February 28,2024

Dementia care at home: Raising knowledge and confidence to improve quality and decrease costs

by New York UniversityOver two thirds or the home health care population consists of adults over the age of 65, approximately 36% have some form of cognitive impairment, including dementia. Accor

Updated on:February 28,2024

Skin may hold key to neurodevelopmental disorder diagnoses

by Rhiannon Koch,University of AdelaideCredit:The American Journal of Human Genetics(2024). DOI: 10.1016/j.ajhg.2024.06.018A genetic diagnostic method using a small sample of skin fr

Updated on: August 08,2024

Skin may hold key to neurodevelopmental disorder diagnoses

by Rhiannon Koch,University of AdelaideCredit:The American Journal of Human Genetics(2024). DOI: 10.1016/j.ajhg.2024.06.018A genetic diagnostic method using a small sample of skin fr

Updated on:August 08,2024

Alzheimer's and aducanumab: Unjust profits and false hopes

by The Hastings CenterCredit: CC0 Public DomainThe U.S. Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's disease raises at leas

Updated on: April 08,2024

Alzheimer's and aducanumab: Unjust profits and false hopes

by The Hastings CenterCredit: CC0 Public DomainThe U.S. Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's disease raises at leas

Updated on:April 08,2024

Scientists discover pathway that may lead to Alzheimer's disease

by Fisher Center for Alzheimer's Research FoundationDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Today, researchers at the Fisher Center for Alzhe

Updated on: February 28,2024

Scientists discover pathway that may lead to Alzheimer's disease

by Fisher Center for Alzheimer's Research FoundationDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Today, researchers at the Fisher Center for Alzhe

Updated on:February 28,2024

New insights into what happens in cells in early Alzheimer's

byEuropean Synchrotron Radiation FacilityThe structure of the ACAD9-ECSIT_CTER complex (ECSIT in red). An international team of researchers, led by the ESRF, have elucidated the structure of the

Updated on: April 09,2024

New insights into what happens in cells in early Alzheimer's

byEuropean Synchrotron Radiation FacilityThe structure of the ACAD9-ECSIT_CTER complex (ECSIT in red). An international team of researchers, led by the ESRF, have elucidated the structure of the

Updated on:April 09,2024

Largest study on infant-type hemispheric glioma reports factors to guide treatment approaches

Updated on: December 11,2025

Largest study on infant-type hemispheric glioma reports factors to guide treatment approaches

Updated on:December 11,2025

Here's how sleep strengthens muscle and bone by boosting growth hormone levels

Updated on: September 27,2025

Here's how sleep strengthens muscle and bone by boosting growth hormone levels

Updated on:September 27,2025

Diabetes drug could influence brain activity in Alzheimer's

by Alzheimer's Research UKResearchers in Denmark have released findings from a small clinical trial of the diabetes drug liraglutide in people living with Alzheimer's disease.Thepil

Updated on: February 28,2024

Diabetes drug could influence brain activity in Alzheimer's

by Alzheimer's Research UKResearchers in Denmark have released findings from a small clinical trial of the diabetes drug liraglutide in people living with Alzheimer's disease.Thepil

Updated on:February 28,2024

Dementia perceived as "illness" rather than aging symptom can lower mood

by Louise Vennells,University of ExeterPeople who perceive dementia symptoms as an illness feel more negative than those who see it as an inevitable part of getting older, a new study indicates.

Updated on: February 28,2024

Dementia perceived as "illness" rather than aging symptom can lower mood

by Louise Vennells,University of ExeterPeople who perceive dementia symptoms as an illness feel more negative than those who see it as an inevitable part of getting older, a new study indicates.

Updated on:February 28,2024

Burning more calories linked with greater gray matter volume, reduced Alzheimer's risk

by University of Pittsburgh Schools of the Health SciencesCredit: Vera Kratochvil/public domainWhether they jog, swim, garden or dance, physically active older persons have larger gray matter vol

Updated on: February 28,2024

Burning more calories linked with greater gray matter volume, reduced Alzheimer's risk

by University of Pittsburgh Schools of the Health SciencesCredit: Vera Kratochvil/public domainWhether they jog, swim, garden or dance, physically active older persons have larger gray matter vol

Updated on:February 28,2024

FDA panel urges rejection of experimental Alzheimer's drug

by Marilynn Marchione and Matthew PerroneIn this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer's disease research in a laboratory at the drugmaker's headquarters in Ca

Updated on: March 30,2024

FDA panel urges rejection of experimental Alzheimer's drug

by Marilynn Marchione and Matthew PerroneIn this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer's disease research in a laboratory at the drugmaker's headquarters in Ca

Updated on:March 30,2024